Esma Saada-Bouzid

机构：Centre Antoine Lacassagne

发表论文 1 篇 · 总被引 1 次 · h-index 1

代表论文

• Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met–Targeting Antibody–Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction Cancer (2026 · Clinical Cancer Research · 被引 1)